PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 22511118-4 2012 Binding studies with purified CYP1B1 suggests that TMS interferes in the proximity of the heme region of CYP1B1 with high affinity. Heme 90-94 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 30-36 22511118-4 2012 Binding studies with purified CYP1B1 suggests that TMS interferes in the proximity of the heme region of CYP1B1 with high affinity. Heme 90-94 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 105-111 17159775-5 2006 RESULTS: The capabilities of the most efficient CYP enzymes oxidizing Sudan I, human and rat recombinant CYP1A1, as well as of human recombinant CYP1A2, 2A6 and 3A4 were significantly increased by b(5), while reactions catalyzed by human CYP1B1, 2C8, 2C9 and 2E1 were insensitive to this heme protein. Heme 288-292 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 238-244 31746392-3 2020 As a heme-thiolate monooxygenase, cytochrome P450 family 1 subfamily B member 1 (CYP1B1) is able to metabolize arachidonic acid into hydroxyeicosatetraenoic acids, which are thought to serve a central function in the pathophysiology of the cardiovascular system. Heme 5-18 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 34-79 31746392-3 2020 As a heme-thiolate monooxygenase, cytochrome P450 family 1 subfamily B member 1 (CYP1B1) is able to metabolize arachidonic acid into hydroxyeicosatetraenoic acids, which are thought to serve a central function in the pathophysiology of the cardiovascular system. Heme 5-18 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 81-87 12732455-3 2003 In general, it appears that the CYP1B1 model is consistent with known substrate selectivity for the enzyme, and the sites of metabolism can be rationalized in terms of specific contacts with key amino acid residues within the CYP1B1 heme locus. Heme 233-237 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 32-38 12732455-3 2003 In general, it appears that the CYP1B1 model is consistent with known substrate selectivity for the enzyme, and the sites of metabolism can be rationalized in terms of specific contacts with key amino acid residues within the CYP1B1 heme locus. Heme 233-237 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 226-232 11854143-8 2002 These results indicate a post-transcriptional inhibitory effect of arsenite on the expression of CYP1A1 and CYP1B1 in T-47D cells, possibly resulting from reduced heme availability. Heme 163-167 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 108-114 10781890-9 2000 The expression proved to be highly dependent upon this heme precursor, with levels of CYP1B1 increasing approximately 20-fold, to 920 nmol/l in the presence of up to 2.5 mM ALA. Heme 55-59 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 86-92 10781890-11 2000 It could be shown that although heme synthesis was not limiting (CYP101 holoenzyme expression in the absence of ALA was four times higher than the ALA-supported CYP1B1 holoenzyme expression), it was necessary for optimal expression of CYP1B1. Heme 32-36 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 235-241 10781890-12 2000 CYP1B1 protein synthesis appears to be coupled to heme precursor availability, as seen by SDS-PAGE, because in the absence of heme precursor apocytochrome P450 1B1 does not accumulate. Heme 50-54 cytochrome P450 family 1 subfamily B member 1 Homo sapiens 0-6